The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key assets underway: olanzapine for treatment of schizophrenia, ...

The company's India business, comprising both formulations and consumer wellness divisions, contributed 38 per cent of ...

CVS is testing a new feature in its mobile app that allows customers to unlock display cabinets and access products like ...